Inhalationssteroid osteoporose

A simple algorithm for the identification of clinical COPD phenotypes. / Burgel, Pierre-Régis; Paillasseur, Jean-Louis; Janssens, Wim; Piquet, Jacques; ter Riet, Gerben; Garcia-Aymerich, Judith; Cosio, Borja; Bakke, Per; Puhan, Milo A.; Langhammer, Arnulf; Alfageme, Inmaculada; Almagro, Pere; Ancochea, Julio; Celli, Bartolome R.; Casanova, Ciro; de-Torres, Juan P.; Decramer, Marc; Echazarreta, Andrés; Esteban, Cristobal; Gomez Punter, Rosa Mar; Han, MeiLan K.; Johannessen, Ane; Kaiser, Bernhard; Lamprecht, Bernd ; Lange, Peter ; Leivseth, Linda; Marin, Jose M.; Martin, Francis; Martinez-Camblor, Pablo; Miravitlles, Marc; Oga, Toru; Sofia Ramírez, Ana; Sin, Don D.; Sobradillo, Patricia; Soler-Cataluna, Juan J.; Turner, Alice M.; Verdu Rivera, Francisco Javier; Soriano, Joan B.; Roche, Nicolas.

Specific pretreatments, drugs to prevent chemically induced lung injuries due to respiratory airway toxins, are not available. Analgesic medications, oxygen, humidification, and ventilator support currently constitute standard therapy. In fact, mechanical ventilation remains the therapeutic mainstay for acute inhalation injury. [39] [40] The cornerstone of treatment is to keep the PaO2 > 60 mmHg ( kPa), without causing injury to the lungs with excessive O2 or volutrauma. Pressure control ventilation is more versatile than volume control, although breaths should be volume limited, to prevent stretch injury to the alveoli. Positive end-expiratory pressure (PEEP) is used in mechanically ventilated patients with ARDS to improve oxygenation. Hemorrhaging, signifying substantial damage to the lining of the airways and lungs, can occur with exposure to highly corrosive chemicals and may require additional medical interventions. Corticosteroids are sometimes administered, and bronchodilators to treat bronchospasms. Drugs that reduce the inflammatory response, promote healing of tissues, and prevent the onset of pulmonary edema or secondary inflammation may be used following severe injury to prevent chronic scarring and airway narrowing. [41]

REK LISTAN 2013 7 ∏ UTBYTBART LÄKEMEDEL AKUT OBSTRUKTION VID ASTMA OCH KOL betametason Betapred ipratropium∏ lösning för nebulisator prednisolon Prednisolon salbutamol∏ lösning för nebulisator teofyllin Teovent, klysma terbutalin Bricanyl, inj theofyllamin Teofyllamin, inj ANDRAHANDSVAL Snabbverkande beta-2-stimulerare salbutamol Airomir/Autohaler Ventoline/Diskus/Evohaler terbutalin Bricanyl/Turbuhaler Långverkande beta-2-stimulerare formoterol Formatris Novolizer Oxis Turbuhaler indakaterol Onbrez Breezhaler salmeterol Serevent Diskus Fosfodiesterashämmare roflumilast Daxas Hosta Inga preparat är subventionerade, gäller både barn och vuxna. Se terapigruppens hemsida. Indikationen för Daxas är KOL vid stadium 3-4 med kronisk bronkit och upprepade exacerbationer. Endast subvention till patient som har provat inhalationssteroid och LABA och bedöms olämplig för inhalationssteroidbehandling. Halv dos initialt pga GI-biverkningar. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 . se /vardgivarstod/andning

Inhalationssteroid osteoporose

inhalationssteroid osteoporose


inhalationssteroid osteoporoseinhalationssteroid osteoporoseinhalationssteroid osteoporoseinhalationssteroid osteoporoseinhalationssteroid osteoporose